New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareEpithalon vs Adipotide

Epithalon vs Adipotide

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
Epithalon
Fat Loss & Metabolic
Adipotide
Summary
Epithalon is a synthetic tetrapeptide developed from the pineal gland extract Epithalamin by Russian scientist Dr. Vladimir Khavinson. It is one of the most researched longevity peptides, known for activating telomerase and extending telomere length — the molecular hallmarks of cellular aging.
Adipotide (FTPP) is a chimeric proapoptotic peptide that selectively targets and destroys blood vessels feeding white adipose tissue. It binds prohibitin on the vasculature of fat tissue, delivering a proapoptotic sequence that induces cell death in fat-specific blood vessels, causing targeted fat tissue regression.
Half-Life
2–4 hours
Estimated 2-4 hours
Admin Route
SubQ, Sublingual
Subcutaneous, Intravenous (research)
Research
Typical Dose
5–10 mg total per cycle
Not established for humans; primate studies used 0.1-1 mg/kg
Frequency
0.5–1 mg daily
Daily for 4 weeks (research protocol)
Key Benefits
  • Activates telomerase enzyme, extending telomere length
  • May slow cellular and biological aging
  • Regulates melatonin production and circadian rhythms
  • Improves sleep quality
  • Powerful antioxidant properties
  • May reduce incidence of age-related diseases
  • Supports immune system function
  • Studied for cancer prevention properties in animal models
  • Targeted reduction of white adipose tissue
  • Promotes fat vasculature apoptosis without systemic toxicity
  • Demonstrated significant fat loss in primate studies
  • Potential for visceral and subcutaneous fat reduction
  • Novel non-hormonal mechanism distinct from GLP-1 agonists
  • Explored for obesity and metabolic syndrome
Side Effects
  • Injection site irritation (mild)
  • Temporary sleep changes during cycle (usually improves)
  • Rare: fatigue
  • Renal toxicity observed in primate studies (transient, dose-dependent)
  • Dehydration and electrolyte imbalances in research
  • Weight regain upon cessation
  • Limited human data; side effect profile largely from animal studies
Stacks With